Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Circulating tumor cells as therapy-related biomarkers in cancer patients.

Gorges TM, Pantel K.

Cancer Immunol Immunother. 2013 May;62(5):931-9. doi: 10.1007/s00262-012-1387-1. Epub 2013 Jan 12. Review.

PMID:
23314304
[PubMed - indexed for MEDLINE]
2.

Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA.

Gorges TM, Schiller J, Schmitz A, Schuetzmann D, Schatz C, Zollner TM, Krahn T, von Ahsen O.

Biomarkers. 2012 Sep;17(6):498-506. doi: 10.3109/1354750X.2012.689133. Epub 2012 May 23.

PMID:
22616911
[PubMed - indexed for MEDLINE]
3.

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.

Gorges TM, Tinhofer I, Drosch M, Röse L, Zollner TM, Krahn T, von Ahsen O.

BMC Cancer. 2012 May 16;12:178. doi: 10.1186/1471-2407-12-178.

PMID:
22591372
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk